Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Rexgenero
Biotech
Ixaka's cell therapy clears interim phase 3 data review
Ixaka said the analysis “is consistent with the effect observed in previous clinical trials" that linked the cells to a 70% complete response rate.
Nick Paul Taylor
Sep 10, 2021 11:05am
Novavax taps Machielse to head manufacturing—Chutes & Ladders
Jul 2, 2020 8:55am
British cell therapy biotech Rexgenero nabs life science veteran
Jul 2, 2020 7:35am
